Investigating the effects of estradiol or estradiol/progesterone treatment on mood, depressive symptoms, menopausal symptoms and subjective sleep quality in older healthy hysterectomized women: A questionnaire study

Neuropsychobiology

Volumn 52, Issue 1, 2005, Pages 17-23

  Heinrich, A B ^a   Wolf, O T ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Depression; Menopause; Mood; Sex steroid treatment; Sleep

Indexed keywords

ESTRADIOL; ESTRADIOL VALERATE; PLACEBO; PROGESTERONE; SEX HORMONE;

ADULT; ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; FEMALE; HORMONE ACTION; HUMAN; HYSTERECTOMY; MENOPAUSAL SYNDROME; MOOD DISORDER; NORMAL HUMAN; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUESTIONNAIRE; SLEEP; WELLBEING;

ADULT; AGED; BREAST DISEASES; DEPRESSION; DOUBLE-BLIND METHOD; ESTRADIOL; FEMALE; HUMANS; HYSTERECTOMY; MENOPAUSE; MIDDLE AGED; MOOD DISORDERS; NEUROPSYCHOLOGICAL TESTS; PROGESTERONE; QUESTIONNAIRES; SLEEP DISORDERS; WECHSLER SCALES;

EID: 21344440762     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000086173     Document Type: Article

References (50)

1. Morley JE: Is the hormonal fountain of youth drying up? J Gerontol A Biol Sci Med Sci 2004;59:M458-M460.
2. McEwen BS, Alves SE: Estrogen actions in the central nervous system. Endocr Rev 1999;20:279-307.
3. Fink G, Sumner BE, McQueen JK, Wilson H, Rosie R: Sex steroid control of mood, mental state and memory. Clin Exp Pharmacol Physiol 1998;25:764-775.
4. Sherwin BB, Suranyi-Cadotte BE: Up-regulatory effect of estrogen on platelet 3H-imipramine binding sites in surgically menopausal women. Biol Psychiatry 1990;28:339-348.
5. Kugaya A, Epperson CN, Zoghbi S, van Dyck CH, Hou Y, Fujita M, et al: Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in postmenopausal women. Am J Psychiatry 2003;160:1522-1524.
6. Moses EL, Drevets WC, Smith G, Mathis CA, Kalro BN, Butters MA et al: Effects of estradiol and progesterone administration on human serotonin 2A receptor binding: a PET study. Biol Psychiatry 2000;48:854-860.
7. Baulieu EE: Neurosteroids: A novel function of the brain. Psychoneuroendocrinology 1998;23:963-987.
8. Rupprecht R, di Michele F, Hermann B, Strohle A, Lancel M, Romeo E et al: Neuroactive steroids: Molecular mechanisms of action and implications for neuropsychopharmacology. Brain Res Brain Res Rev 2001;37:59-67.
9. Gruber CJ, Huber JC: Differential effects of progestins on the brain. Maturitas 2003;46(suppl 1):S71-S75.
10. Sherwin BB: Progestogens used in menopause. Side effects, mood and quality of life. J Reprod Med 1999;44(suppl 2):227-232.
11. Steiger A: Sleep and endocrine regulation. Front Biosci 2003;8:358-376.
12. Moline ML, Broch L, Zak R, Gross V: Sleep in women across the life cycle from adulthood through menopause. Sleep Med Rev 2003;7:155-177.
13. Mitwally MF, Kahn LS, Halbreich U: Pharmacotherapy of premenstrual syndromes and premenstrual dysphoric disorder: current practices. Expert Opin Pharmacother 2002;3:1577-1590.
14. Bloch M, Daly RC, Rubinow DR: Endocrine factors in the etiology of postpartum depression. Compr Psychiatry 2003;44:234-246.
15. Halbreich U: The pathophysiologic background for current treatments of premenstrual syndromes. Curr Psychiatry Rep 2002;4:429-434.
16. Zweifel JE, O'Brien WH: A meta-analysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrinology 1997;22:189-212.
17. Hays J, Ockene JK, Brunner RL, Kotchen JM, Manson JE, Patterson RE et al: Effects of estrogen plus progestin on health-related quality of life. N Engl J Med 2003;348:1839-1854.
18. Hlatky MA, Boothroyd D, Vittinghoff E, Sharp P, Whooley MA: Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: Results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial. JAMA 2002;287:591-597.
19. Kritz-Silverstein D, Von Muhlen DG, Ganiats TG, Barrett-Connor E: Hysterectomy status, estrogen use and quality of life in older women: The Rancho Bernardo study. Qual Life Res 2004;13:55-62.
20. Whooley MA, Grady D, Cauley JA: Postmenopausal estrogen therapy and depressive symptoms in older women. J Gen Intern Med 2000;15:535-541.
21. Sherwin BB: The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women. J Clin Endocrinol Metab 1991;72:336-343.
22. Bethea CL, Mirkes SJ, Shively CA, Adams MR: Steroid regulation of tryptophan hydroxylase protein in the dorsal raphe of macaques. Biol Psychiatry 2000;47:562-576.
23. Walpurger V, Pietrowsky R, Djahansouzi S, Wolf OT: No changes in event-related potentials with estrogen or estrogen plus progesterone treatment in healthy older hysterectomized women: Results from a double-blind, placebo-controlled study. Psychopharmacology, in press.
24. Wolf OT, Heinrich AB, Hanstein B, Kirschbaum C: Estradiol or estradiol/progesterone treatment in older women: No strong effects on cognition. Neurobiol Aging 2005;26:1029-1033.
25. Hautzinger M: Allgemeine Depressions-Skala: ADS. Weinheim, Beltz, 1993.
26. Wechsler D: Wechsler Adult Intelligence Scale - Revised. New York, Harcourt Brace Jovanovich, 1981.
27. Folstein MF, Folstein SE, McHugh PR: 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
28. Pocock SJ, Simon R: Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 1975;31:103-115.
29. Radloff LS: The CES-D scale: A self-reported depression scale for research in the general population. Appl Psych Measure 1977;1:385-401.
30. Himmelfarb S, Murrell SA: Reliability and validity of five mental health scales in older persons. J Gerontol 1983;38:333-339.
31. McCallum J, Mackinnon A, Simons L, Simons J: Measurement properties of the Center for Epidemiological Studies Depression Scale: An Australian community study of aged persons. J Gerontol 1995;50:S182-S189.
32. Steyer R, Schwenkmezger P, Notz P, Eid M: Testtheoretische Analysen des Mehrdimensionalen Befindlichkeitsfragebogens (MDBF). Diagnostica 1994;40:320-328.
33. Straus JL, von Ammon CS: Placebo effects. Issues for clinical practice in psychiatry and medicine. Psychosomatics 1996;37:315-326.
34. Gambacciani M, Ciaponi M, Cappagli B, Monteleone P, Benussi C, Bevilacqua G et al: Effects of low-dose, continuous combined estradiol and noretisterone acetate on menopausal quality of life in early postmenopausal women. Maturitas 2003;44:157-163.
35. Morrison MF, Kallan MJ, Ten Have T, Katz I, Tweedy K, Battistini M: Lack of efficacy of estradiol for depression in postmenopausal women: A randomized, controlled trial. Biol Psychiatry 2004;55:406-412.
36. Allolio B, Arlt W: DHEA treatment: Myth or reality? Trends Endocrinol Metab 2002;13:288-294.
37. Wolf OT, Kirschbaum C: Dehydroepiandrosterone replacement in elderly individuals: Still waiting for the proof of beneficial effects on mood or memory. J Endocrinol Invest 1999;22:316.
38. Wolf OT, Kirschbaum C: Wishing a dream came true: DHEA as a rejuvenating treatment? J Endocrinol Invest 1998;21:133-135.
39. Olshansky SJ, Hayflick L, Perls TT: The hype and the reality - part I. J Gerontol 2004;59:B513-B514.
40. Fitzpatrick LA, Pace C, Wiita B: Comparison of regimens containing oral micronized progesterone or medroxyprogesterone acetate on quality of life in postmenopausal women: A cross-sectional survey. J Womens Health Gend Based Med 2000;9:381-387.
41. Antonijevic IA, Stalla GK, Steiger A: Modulation of the sleep electroencephalogram by estrogen replacement in postmenopausal women. Am J Obstet Gynecol 2000;182:277-282.
42. Polo-Kantola P, Erkkola R, Irjala K, Pullinen S, Virtanen I, Polo O: Effect of short-term transdermal estrogen replacement therapy on sleep: A randomized, double-blind crossover trial in postmenopausal women. Fertil Steril 1999;71:873-880.
43. Saletu-Zyhlarz G, Anderer P, Gruber G, Mandl M, Gruber D, Metka M, et al: Insomnia related to postmenopausal syndrome and hormone replacement therapy: Sleep laboratory studies on baseline differences between patients and controls and double-blind, placebo-controlled investigations on the effects of a novel estrogen-progestogen combination (Climodien, Lafamme) versus estrogen alone. J Sleep Res 2003;12:239-254.
44. Polo-Kantola P, Saaresranta T, Polo O: Aetiology and treatment of sleep disturbances during perimenopause and postmenopause. CNS Drugs 2001;15:445-452.
45. Friess E, Tagaya H, Trachsel L, Holsboer F, Rupprecht R: Progesterone-induced changes in sleep in male subjects. Am J Physiol 1997;272:E885-E891.
46. Lancel M, Faulhaber J, Holsboer F, Rupprecht R: Progesterone induces changes in sleep comparable to those of agonistic GABAA receptor modulators. Am J Physiol 1996;271:E763-E772.
47. Anderer P, Saletu B, Saletu-Zyhlarz G, Gruber D, Metka M, Huber J, et al: Brain regions activated during an auditory discrimination task in insomniac postmenopausal patients before and after hormone replacement therapy: Low-resolution brain electromagnetic tomography applied to event-related potentials. Neuropsychobiology 2004;49:134-153.
48. Buysse DJ, Reynolds CF, III, Monk TH, Berman SR, Kupfer DJ: The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res 1989;28:93-213.
49. Grady D: Postmenopausal hormones - therapy for symptoms only. N Engl J Med 2003;348:1835-1837.
50. Grady D, Ettinger B, Tosteson AN, Pressman A, Macer JL: Predictors of difficulty when discontinuing postmenopausal hormone therapy. Obstet Gynecol 2003;102:1233-1239.